Asceneuron wins the Universal Biotech Innovation Prize 2014. Open to young innovative companies, academic and private researchers, the Universal Biotech Innovation Prize aims to acknowledge on an international scale, the most innovative early stage projects in life sciences.

by Admin-asceneuron | Oct 6, 2014 | News

Asceneuron wins the Universal Biotech Innovation Prize 2014. Open to young innovative companies, academic and private researchers, the Universal Biotech Innovation Prize aims to acknowledge on an international scale, the most innovative early stage projects in life sciences.

An exceptional and unexpected outcome of the 2014 edition of the Universal Biotech Innovation Prize has surprised the audience: the 6th edition has 2 winners, one best Biotech project and one best Medtech project.

Posted :

Read the article

CurePSP awards a research grant to Asceneuron to study the role of O-linked protein glycosylation in the spread of tau pathology.

by Admin-asceneuron | Feb 10, 2014 | News

CurePSP awards a research grant to Asceneuron to study the role of O-linked protein glycosylation in the spread of tau pathology.

CurePSP is the foremost non-profit organization dedicated to increasing awareness of progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), and other atypical Parkinsonian disorders; funding research toward treatment, cure and prevention; educating healthcare professionals; and providing support, information and hope for affected persons and their families.

Posted :

Read the article

Asceneuron presents the novel M1-targeting compound ASN-51 at the 11th International Conference on Alzheimer’s and Parkinson’s disease held 6-10 March 2013 in Florence, Italy.

by Admin-asceneuron | Mar 7, 2013 | Event

Asceneuron presents the novel M1-targeting compound ASN-51 at the 11th International Conference on Alzheimer’s and Parkinson’s disease held 6-10 March 2013 in Florence, Italy.

Read the comments in the Alzheimer Reseach Forum News of March 26th, 2013: click here

Posted :